Friday, 5 January 2018

FDA expands use of Amgen's blockbuster drug

(Reuters) - Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)